SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-23-092268
Filing Date
2023-12-04
Accepted
2023-12-01 21:43:05
Documents
105
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 6-K ea189176-6ka1_fresh2.htm   iXBRL 6-K/A 31296
2 UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF JUNE 30, 2023 ea189176ex99-1_fresh2.htm   iXBRL EX-99.1 1121373
3 MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS ea189176ex99-2_fresh2.htm EX-99.2 73564
  Complete submission text file 0001213900-23-092268.txt   9089358

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE anpc-20230630.xsd EX-101.SCH 116022
5 XBRL CALCULATION FILE anpc-20230630_cal.xml EX-101.CAL 59880
6 XBRL DEFINITION FILE anpc-20230630_def.xml EX-101.DEF 483628
7 XBRL LABEL FILE anpc-20230630_lab.xml EX-101.LAB 895560
8 XBRL PRESENTATION FILE anpc-20230630_pre.xml EX-101.PRE 509657
99 EXTRACTED XBRL INSTANCE DOCUMENT ea189176-6ka1_fresh2_htm.xml XML 1161809
Mailing Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108
Business Address 650 FIFTH AVENUE SUITE 2416 NEW YORK NY 10019-6108 1 917-397-6890
Fresh2 Group Ltd (Filer) CIK: 0001786511 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: 6-K/A | Act: 34 | File No.: 001-39137 | Film No.: 231461164
SIC: 8071 Services-Medical Laboratories